Eicosapentaenoic acid suppression of systemic inflammatory responses and inverse up‐regulation of 15‐deoxyΔ12,14Prostaglandin J2 production
Authors:
Open Access
- 16 April 2013
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 169 (5) , 1130-1139
Abstract
Background and Purpose: Eicosapentaenoic acid (EPA) has been shown to suppress immune cell responses, such as cytokine production and downstream PG production in vitro. Studies in vivo, however, have used EPA as a minor constituent of fish oil with variable results. We investigated the effects of EPA on systemic inflammatory responses as pure EPA has not been evaluated on immune/inflammatory responses in vivo.Experimental Approach: Rabbits were administered polyinosinic: polycytidylic acid (poly I:C) i.v. before and after oral treatment with EPA for 42 days (given daily). The responses to IL‐1β and TNF‐α were also studied. Immediately following administration of poly I:C, body temperature was continuously monitored and blood samples were taken. Plasma levels of IL‐1β, PGE2 (PGE2), and 15‐deoxy‐Δ12,14‐PGJ2 (15d‐PGJ2) were measured by enzyme immunoassay.Key Results: Following EPA treatment, the fever response to poly I:C was markedly suppressed compared with pretreatment responses. This was accompanied by a parallel reduction in the poly I:C‐stimulated elevation in plasma levels of IL‐1β and PGE2. Paradoxically, the levels of 15d‐PGJ2 were higher following EPA treatment. EPA treatment did not significantly alter the fever response or plasma levels of PGE2 in response to either IL‐1β or TNF‐α.Conclusion and Implications: Oral treatment with EPA can suppress immune/inflammatory responses in vivo via a suppression of upstream cytokine production resulting in a decreased fever response and indirectly reducing circulating levels of PGE2. EPA also enhances the production of the cytoprotective prostanoid 15d‐PGJ2 indicating the therapeutic benefit of EPA.Keywords
This publication has 52 references indexed in Scilit:
- Effect of Fish Oil Supplementation on Fasting Vascular Endothelial Function in Humans: A Meta-Analysis of Randomized Controlled TrialsPLOS ONE, 2012
- Effects of fish oil supplementation on inflammatory markers in chronic heart failure: a meta-analysis of randomized controlled trialsBMC Cardiovascular Disorders, 2012
- Therapeutic implications of disorders of cell death signalling: membranes, micro‐environment, and eicosanoid and docosanoid metabolismBritish Journal of Pharmacology, 2012
- Guide to Receptors and Channels (GRAC), 5th editionBritish Journal of Pharmacology, 2011
- Higher n−3 fatty acids are associated with more intense fenfluramine-induced ACTH and cortisol responses among cocaine-abusing menPsychiatry Research, 2011
- Eicosapentaenoic acid inhibits voltage‐gated sodium channels and invasiveness in prostate cancer cellsBritish Journal of Pharmacology, 2009
- Increased Plasma Levels of 15-Deoxy Δ Prostaglandin J 2 Are Associated With Good Outcome in Acute Atherothrombotic Ischemic StrokeStroke, 2005
- Inhibition of cytokine-stimulated thymic lymphocyte proliferation by fatty acids: The role of eicosanoidsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1994
- Attenuation of the Febrile Response in Guinea Pigs by Fish Oil Enriched DietsJournal of Parenteral and Enteral Nutrition, 1989
- Prostaglandins E3 and F3α are excreted in human urine after ingestion of n−3 polyunsaturated fatty acidsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1988